Synageva BioPharma (GEVA)

[surf1944]

Trimeris shareholder adviser asks company to consider sale
Tue Aug 14, 2007 8:17AM EDT

Aug 14 (Reuters) - HealthCor Management L.P., an investment adviser to funds that own shares of biotechnology company Trimeris Inc. (TRMS.O: Quote, Profile, Research), today asked the company to seek strategic alternatives, such as a sale.

In a filing with the U.S. Securities and Exchange Commission, HealthCor said Trimeris' plan to continue development of next generation fusion inhibitors -- drugs that target HIV -- will continue to depress its value.

HealthCor also increased its stake in the company to 15.04 percent from 9.43 percent. (Reporting by Varsha Tickoo in Bangalore)